NCT03785964 2025-01-31DeFiSpringWorks Therapeutics, Inc.Phase 3 Completed142 enrolled 21 charts 1 FDA
NCT02066181 2023-06-07Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisNational Cancer Institute (NCI)Phase 3 Completed87 enrolled 14 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts